Efficacy and site-specificity of adenoviral vector integration mediated by the phage φc31 integrase

Human Gene Therapy Methods

Volumn 23, Issue 6, 2012, Pages 393-407

  Robert, Marc André ^a,b   Zeng, Yue ^a,c   Raymond, Benoît ^a   Desfossé, Laurie ^a   Mairey, Emilie ^a   Tremblay, Jacques P ^d   Massie, Bernard ^a,b   Gilbert, Rénald ^a,c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BACTERIAL ENZYME; HISTONE H2AX; INTEGRASE; PHI C31 INTEGRASE; PLASMID DNA; PUROMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; CELL VIABILITY; CELLS; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; GENETIC RESISTANCE; GENETIC TRANSFECTION; GENOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION;

ADENOVIRIDAE; ANIMALS; BACTERIOPHAGES; BASE SEQUENCE; CELL LINE; GENETIC LOCI; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HISTONES; HUMANS; INTEGRASES; MICE; TRANSDUCTION, GENETIC;

EID: 84876735529     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.122     Document Type: Article

References (57)

1. Al Yacoub, N., Romanowska, M., Haritonova, N., et al. (2007). Optimized production and concentration of lentiviral vectors containing large inserts. J Gene Med 9, 579-584. (Pubitemid 47073990)
2. Andreas, S., Schwenk, F., Kuter-Luks, B., et al. (2002). Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res 30, 2299-2306. (Pubitemid 34618980)
3. Aneja, M.K., Imker, R., and Rudolph, C. (2007). Phage phiC31 integrase-mediated genomic integration and long-term gene expression in the lung after nonviral gene delivery. J Gene Med 9, 967-975. (Pubitemid 350104411)
4. Bertoni, C., Jarrahian, S., Wheeler, T.M., et al. (2006). Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc Natl Acad Sci USA 103, 419-424. (Pubitemid 43122416)
5. Calos, M.P. (2006). The phiC31 integrase system for gene therapy. Curr Gene Ther 6, 633-645. (Pubitemid 44890547)
6. Chalberg, T.W., Portlock, J.L., Olivares, E.C., et al. (2006). Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol 357, 28-48. (Pubitemid 43339312)
7. Chen, J.Z., Ji, C.N., Xu, G.L., et al. (2006). DAXX interacts with phage PhiC31 integrase and inhibits recombination. Nucleic Acids Res 34, 6298-6304.
8. Deol, J.R., Danialou, G., Larochelle, N., et al. (2007). Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin. Mol Ther 15, 1767-1774. (Pubitemid 47434182)
9. Dropulic, B. (2011). Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research. Hum Gene Ther 22, 649-657.
10. Ehrhardt, A., Xu, H., Huang, Z., et al. (2005). A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase. Mol Ther 11, 695-706. (Pubitemid 40567974)
11. Ehrhardt, A., Engler, J.A., Xu, H., et al. (2006). Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. Hum Gene Ther 17, 1077-1094. (Pubitemid 44749710)
12. Ehrhardt, A., Yant, S.R., Giering, J.C., et al. (2007). Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo. Mol Ther 15, 146-156. (Pubitemid 46043660)
13. Fredman, J.N., and Engler, J.A. (1993). Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro. J Virol 67, 3384-3395. (Pubitemid 23143713)
14. Gilbert, R., Nalbantoglu, J., Howell, J.M., et al. (2001). Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by transacting adenoviral gene products. Hum Gene Ther 12, 1741-1755. (Pubitemid 32911640)
15. Gilbert, R., Liu, A., Petrof, B., et al. (2002). Improved performance of a fully gutted adenovirus vector containing two fulllength dystrophin cDNAs regulated by a strong promoter. Mol Ther 6, 501-509. (Pubitemid 35214872)
16. Gilbert, R., Dudley, R.W., Liu, A.B., et al. (2003). Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helperdependent (gutted) adenovirus-encoding murine dystrophin. Hum Mol Genet 12, 1287-1299. (Pubitemid 36722609)
17. Goncalves, M.A., Holkers, M., Van Nierop, G.P., et al. (2008). Targeted chromosomal insertion of large DNA into the human genome by a fiber-modified high-capacity adenovirus-based vector system. PLoS One 3, e3084.
18. Groth, A.C., Olivares, E.C., Thyagarajan, B., et al. (2000). A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci USA 97, 5995-6000. (Pubitemid 30367512)
19. Harui, A., Suzuki, S., Kochanek, S., et al. (1999). Frequency and stability of chromosomal integration of adenovirus vectors. J Virol 73, 6141-6146. (Pubitemid 29274908)
20. Held, P.K., Olivares, E.C., Aguilar, C.P., et al. (2005). In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Mol Ther 11, 399-408. (Pubitemid 40277316)
21. Hillgenberg, M., Tonnies, H., Strauss, M. (2001). Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer. J Virol 75, 9896-9908. (Pubitemid 32900124)
22. Ishikawa, Y., Tanaka, N., Murakami, K., et al. (2006). Phage phiC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines. J Gene Med 8, 646-653. (Pubitemid 43827257)
23. Keravala, A., Chavez, C.L., Hu, G., et al. (2011). Long-term phenotypic correction in factor IX knockout mice by using phiC31 integrase-mediated gene therapy. Gene Ther 18, 842-848.
24. Kreiss, P., Cameron, B., Rangara, R., et al. (1999). Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 27, 3792-3798. (Pubitemid 29454426)
25. Kreppel, F., and Kochanek, S. (2004). Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J Virol 78, 9-22. (Pubitemid 37549715)
26. Liu, J., Skjorringe, T., Gjetting, T., et al. (2009). PhiC31 integrase induces a DNA damage response and chromosomal rearrangements in human adult fibroblasts.BMCBiotechnol 9, 31.
27. Liu, Q., Perez, C.F., and Wang, Y. (2006). Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector. J Virol 80, 1672-1679. (Pubitemid 43228709)
28. Mah, L.J., El-Osta, A., and Karagiannis, T.C. (2010). gamma-H2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24, 679-686.
29. Massie, B., Couture, F., Lamoureux, L., et al. (1998). Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J Virol 72, 2289-2296. (Pubitemid 28100788)
30. Mates, L., Chuah, M.K., Belay, E., et al. (2009). Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41, 753-761.
31. Maucksch, C., Aneja, M.K., Hennen, E., et al. (2008). Cell type differences in activity of the Streptomyces bacteriophage phiC31 integrase. Nucleic Acids Res 36, 5462-5471.
32. Meneses-Acosta, A., Dormond, E., Jacob, D., et al. (2008). Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions. J Virol Methods 148, 106-114.
33. Mitchell, R.S., Beitzel, B.F., Schroder, A.R., et al. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2, E234.
34. Murnane, J.P., Yezzi, M.J., and Young, B.R. (1990). Recombination events during integration of transfected DNA into normal human cells. Nucleic Acids Res 18, 2733-2738.
35. Ohbayashi, F., Balamotis, M.A., Kishimoto, A., et al. (2005). Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc Natl Acad Sci USA 102, 13628-13633. (Pubitemid 41420899)
36. Olivares, E.C., Hollis, R.P., Chalberg, T.W., et al. (2002). Sitespecific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 20, 1124-1128. (Pubitemid 35285441)
37. Ortiz-Urda, S., Thyagarajan, B., Keene, D.R., et al. (2003). PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther 14, 923-928. (Pubitemid 36693800)
38. Quenneville, S.P., Chapdelaine, P., Rousseau, J., et al. (2004). Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther 10, 679-687. (Pubitemid 39272857)
39. Quenneville, S.P., Chapdelaine, P., Rousseau, J., et al. (2007). Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Gene Ther 14, 514-522. (Pubitemid 46390924)
40. Raymond, C.S., and Soriano, P. (2007). High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS One 2, e162.
41. Recchia, A., Perani, L., Sartori, D., et al. (2004). Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Mol Ther 10, 660-670. (Pubitemid 39272855)
42. Robert, M.A., Lin, Y., Bendjelloul, M., et al. (2012). Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors. J Gene Med 14, 746-760.
43. Schaack, J., Ho, W.Y., Freimuth, P., et al. (1990). Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev 4, 1197-1208.
44. Sharma, N., Moldt, B., Dalsgaard, T., et al. (2008). Regulated gene insertion by steroid-induced PhiC31 integrase. Nucleic Acids Res 36, e67.
45. Sinn, P.L., Sauter, S.L., and Mccray, P.B., Jr. (2005). Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12, 1089-1098. (Pubitemid 41030614)
46. Sivalingam, J., Krishnan, S., Ng, W.H., et al. (2010). Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells. Mol Ther 18, 1346-1356.
47. Smith, M.C., Brown, W.R., Mcewan, A.R., et al. (2010). Sitespecific recombination by phiC31 integrase and other large serine recombinases. Biochem Soc Trans 38, 388-394.
48. Soifer, H.S., and Kasahara, N. (2004). Retrotransposon-adenovirus hybrid vectors: efficient delivery and stable integration of transgenes via a two-stage mechanism. Curr Gene Ther 4, 373-384. (Pubitemid 39534753)
49. Stephen, S.L., Sivanandam, V.G., and Kochanek, S. (2008). Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA. J Gene Med 10, 1176-1189.
50. Thyagarajan, B., Olivares, E.C., Hollis, R.P., et al. (2001). Sitespecific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21, 3926-3934. (Pubitemid 32476454)
51. Thyagarajan, B., Liu, Y., Shin, S., et al. (2008). Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 26, 119-126.
52. Umana, P., Gerdes, C.A., Stone, D., et al. (2001). Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat Biotechnol 19, 582-585. (Pubitemid 32521193)
53. Vetrini, F., and Ng, P. (2010). Gene therapy with helperdependent adenoviral vectors: current advances and future perspectives. Viruses 2, 1886-1917.
54. Wilber, A., Ulloa Montoya, F., Hammer, L., et al. (2011). Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells. Stem Cells Int 2011, 717069.
55. Woodard, L.E., Hillman, R.T., Keravala, A., et al. (2010a). Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity. Gene Ther 17, 217-226.
56. Woodard, L.E., Keravala, A., Jung, W.E., et al. (2010b). Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma. PLoS One 5, e11367.
57. Wurtele, H., Little, K.C., and Chartrand, P. (2003). Illegitimate DNAintegration in mammalian cells. Gene Ther 10, 1791-1799.